Safety and efficacy of intravenous thrombolytic therapy in the extended window up to 24 hours: A systematic review and meta‐analysis

Objective About 25% of patients with acute ischemic stroke (AIS) present within the intravenous thrombolytic (IVT) therapeutic window of

Saved in:
Bibliographic Details
Published in:Annals of clinical and translational neurology 2024-12, Vol.11 (12), p.3310-3319
Main Authors: Al‐Janabi, Omar M., Jazayeri, Seyed Behnam, Toruno, Michelle A., Mahmood, Yamama M., Ghozy, Sherief, Yaghi, Shadi, Rabinstein, Alejandro A., Kallmes, David F.
Format: Article
Language:English
Subjects:
Administration, Intravenous
Age
Clinical trials
Fibrinolytic Agents - administration & dosage
Fibrinolytic Agents - adverse effects
Humans
Ischemia
Ischemic Stroke - drug therapy
Ischemic Stroke - mortality
Mortality
Patients
Stroke
Systematic review
Thrombolytic Therapy - adverse effects
Thrombolytic Therapy - methods
Time-to-Treatment
Tissues
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Objective About 25% of patients with acute ischemic stroke (AIS) present within the intravenous thrombolytic (IVT) therapeutic window of
ISSN:2328-9503
2328-9503
DOI:10.1002/acn3.52239